National Multicenter Trial Evaluating Two Treatments in Patients With Primary Human Immunodeficiency Virus (HIV-1) Infection

NCT02987530 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

101

Enrollment

OTHER_GOV

Sponsor class

Conditions

HIV-1 Infection

Interventions

DRUG: Dolutegravir
DRUG: Darunavir-cobicistat
DRUG: Emtricitabine-Tenofovir

Sponsor

ANRS, Emerging Infectious Diseases

Collaborators

[object Object]